Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
07/17/2012 | CA2498212C Multi-layered hemostatic dressing comprising thrombin and fibrinogen |
07/17/2012 | CA2478478C Coupling hydroxyalkyl starch via a terminal aldehyde group or a functional group derived therefrom, to a protein |
07/17/2012 | CA2476538C Use of erythropoietin for the preventive or curative treatment of cardiac failure |
07/17/2012 | CA2448265C Methods and compounds for the diagnosis of inflammatory disease and identification of pharmacological agents |
07/17/2012 | CA2446201C Improved neuronal gene transfer |
07/17/2012 | CA2402015C Beta 1, 2-xylosyltransferase-gene from arabidopsis |
07/17/2012 | CA2391392C Methods for screening candidate drugs that disrupt mif and jab1 interaction, mif and jab1 complex, antibodies and uses thereof |
07/17/2012 | CA2355976C Vascular endothelial cell growth factor antagonists and uses thereof |
07/17/2012 | CA2322559C Compositions and methods for modulating vascularization |
07/17/2012 | CA2277486C Synthetic antibiotics |
07/17/2012 | CA2266325C A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
07/12/2012 | WO2012094679A2 Compositions and methods for delivery of high-affinity oxygen binding agents to tumors |
07/12/2012 | WO2012094653A2 Compositions and methods for macromolecular drug delivery |
07/12/2012 | WO2012094512A2 Myocardial tissue targeting peptides |
07/12/2012 | WO2012094297A1 Azuvirin peptides |
07/12/2012 | WO2012094004A1 Fusion of peptidoglycan hydrolase enzymes to a protein transduction domain allows eradication of both extracellular and intracellular gram positive pathogens |
07/12/2012 | WO2012093931A1 Antimicrobial fusion compounds and uses thereof |
07/12/2012 | WO2012093753A1 Artificial saliva comprising hyaluronic acid |
07/12/2012 | WO2012093293A1 Process for preparation of caspofungin acetate and intermediates |
07/12/2012 | WO2012093258A2 Treatment and screening |
07/12/2012 | WO2012093132A1 Plasminogen and plasmin variants |
07/12/2012 | WO2012092760A1 Method for obtaining strains highly expressing lipase and use of lipase obtained |
07/12/2012 | WO2012064697A3 Materials presenting notch signaling molecules to control cell behavior |
07/12/2012 | WO2012062925A3 Compounds and methods for treating pain |
07/12/2012 | WO2012058585A3 Treatment of heart failure with natriuretic peptides |
07/12/2012 | WO2012049430A3 Hydrolysates of animal proteins of marine origin with neuroprotective properties |
07/12/2012 | WO2012048214A9 Use of hyaluronan for promoting angiogenesis |
07/12/2012 | WO2012031023A3 Treatment of inflammatory bowel diseases using a tripeptide |
07/12/2012 | WO2011163228A3 Phage-gnrh constructs, their mimics, antigenic compositions, and sequences for immunocontraception of animals and other applications |
07/12/2012 | WO2011156751A3 Immunogenic vaccine |
07/12/2012 | WO2011152618A4 Non-diffusive botulinum toxin causing local muscle paralysis, and purification method thereof |
07/12/2012 | WO2011133960A3 Lysosomal storage disease enzyme |
07/12/2012 | WO2011116245A3 Methods of treating inflammation |
07/12/2012 | WO2009073909A8 Cyclic, cystein-free protein |
07/12/2012 | US20120179772 System and method to improve fitness training |
07/12/2012 | US20120179090 Transmucosal delivery of therapeutic agents and methods of use thereof |
07/12/2012 | US20120178917 Rna aptamers and methods for identifying the same |
07/12/2012 | US20120178912 RECEPTOR ACTIVATOR OF NF-kappaB |
07/12/2012 | US20120178792 Drg11-responsive (dragon) gene family |
07/12/2012 | US20120178784 Use Of Inhibitors Of The Renin-Angiotensin System |
07/12/2012 | US20120178703 Multimeric polypeptides of hla-g including at least two alpha3 domains and pharmaceutical uses thereof |
07/12/2012 | US20120178702 Stable lipid-comprising drug delivery complexes and methods for their production |
07/12/2012 | US20120178701 Melanocortin Receptor-Specific Peptides |
07/12/2012 | US20120178700 Peptidomimetic macrocycles |
07/12/2012 | US20120178699 Klotho protein and related compounds for the treatment and diagnosis of cancer |
07/12/2012 | US20120178698 Agents and Uses Thereof |
07/12/2012 | US20120178697 Compositions and methods for the inhibition of dishevelled proteins |
07/12/2012 | US20120178696 Compositions and Methods for Modulating AMPA Receptor-mediated Excitotoxicity |
07/12/2012 | US20120178695 Methods of treating neuropathic pain |
07/12/2012 | US20120178694 Modified Compstatin With Peptide Backbone And C-Terminal Modifications |
07/12/2012 | US20120178693 Cofactors for Thrombin Activation of Factor VII and Uses Thereof |
07/12/2012 | US20120178692 Dosage forms of polymer-factor viii moiety conjugates |
07/12/2012 | US20120178691 Factor viii compositions and methods of making and using same |
07/12/2012 | US20120178690 Novel netrin derivatives and uses thereof |
07/12/2012 | US20120178689 Methods of treatment with natriuretic peptides |
07/12/2012 | US20120178688 Therapeutic agents for reducing parathyroid hormone levels |
07/12/2012 | US20120178687 Suspension formulations of insulinotropic peptides and uses thereof |
07/12/2012 | US20120178686 Chemical induction of lactation |
07/12/2012 | US20120178685 Fgf21 mutants and uses thereof |
07/12/2012 | US20120178684 Surgical Calcium Phosphate Citrate-Containing Cement and Method of Manufacturing the Same |
07/12/2012 | US20120178683 Vegf antagonist formulations |
07/12/2012 | US20120178682 GB1 Peptidic Compounds and Methods for Making and Using the Same |
07/12/2012 | US20120178681 Bipiperidinyl compounds, compositions, containing such compounds and methods of treatment |
07/12/2012 | US20120178680 Glycoside derivatives and uses thereof |
07/12/2012 | US20120178679 Fused aromatic ptp-ib inhibitors |
07/12/2012 | US20120178678 Derivatives of 2h pyridazin- 3 -ones, their preparation and their use as scd-1 inhibitors |
07/12/2012 | US20120178677 Soft protease inhibitors, and pro-soft forms thereof |
07/12/2012 | US20120178676 Pegylated c-peptide |
07/12/2012 | US20120178675 Compositions And Methods For Modulating The Pharmacokinetics and Pharmacodynamics of Insulin |
07/12/2012 | US20120178674 Mixture of non-digestible oligosaccharides for stimulating the immune system |
07/12/2012 | US20120178673 Fat accumulation suppressor |
07/12/2012 | US20120178672 Compositions and Methods for Sparing Muscle in Renal Insufficiency and During Hemodialysis |
07/12/2012 | US20120178671 Inhibition of nfk-b mediated virus replication with specific oligosaccharides |
07/12/2012 | US20120178670 Acylated glucagon analogues |
07/12/2012 | US20120178669 Protease inhibitors, compositions and methods of use |
07/12/2012 | US20120178668 Proteinaceous compounds and uses therefor |
07/12/2012 | US20120178667 Methods for treating septic shock |
07/12/2012 | US20120178666 Prodrugs of guanfacine |
07/12/2012 | US20120178629 Apparatus and methods for preparing an emulsion |
07/12/2012 | US20120178163 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same |
07/12/2012 | US20120178107 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
07/12/2012 | US20120177744 Method of using beta-hydroxy-beta-methylbutyrate for the treatment of cancer |
07/12/2012 | US20120177740 Drug delivery formulation for controlling of initial burst and manufacturing method thereof |
07/12/2012 | US20120177737 High drug load tablet |
07/12/2012 | US20120177726 Medical use of spla2 hydrolysable liposomes |
07/12/2012 | US20120177722 Lyaseenzymes, Nucleic Acids Encoding Them and Methods For Making and Using Them |
07/12/2012 | US20120177721 Formulation |
07/12/2012 | US20120177720 Multi-layer wound dressings |
07/12/2012 | US20120177719 Medical device intended to come into contact with a patient's tissue and related manufacturing method |
07/12/2012 | US20120177718 Wound-covering material |
07/12/2012 | US20120177717 Sustained drug delivery system |
07/12/2012 | US20120177715 Heparin cofactor ii fragments with anti-inflammatory and anti-coagulant activity |
07/12/2012 | US20120177702 Solid Forms for Tissue Repair |
07/12/2012 | US20120177699 Preparation Method of Drug Loaded Emulsion |
07/12/2012 | US20120177697 Excipients In Drug Delivery Vehicles |
07/12/2012 | US20120177695 Bioerodible Silicon-Based Devices for Delivery of Therapeutic Agents |
07/12/2012 | US20120177692 Delivery systems for solubilising water-insoluble pharmaceutical active ingredients |
07/12/2012 | US20120177676 Alphabodies for hiv entry inhibition |
07/12/2012 | US20120177674 Compositions comprising fungal immunomodulatory protein and use thereof |
07/12/2012 | US20120177667 Metal Abstraction Peptide (MAP) Tag and Associated Methods |